I am feeling it...news next week.
Call it educated intuition...
Love these shares in the thirties...bought more this week
My DD has been consistent and intense...absolutely confident in my IPIX investment
I am not ignoring the risk, but Brilacidin is absolutely solid:
ABSSI...solid...large phase 2 blinded study showed good safety profile with comparable efficacy to Daptomycin with 1 IV dose
Oral Mucositis...solid results in stage 2 trial...BTD?
Ulcerative colitis promising stage 2 results in a disorder with large numbers of patients with treatment options that can be dismal.
Other potential applications in large profitable markets are sure to be studied eg IBD, Crohns, eye,ear, acne, diabetic ulcers,atopic dermatitis and others
IMO partnership for Brilacidin is virtually assured.
Prurisol awaiting results Stage 2a trial showed reason for optimism for higher doses, but even if the trial is disappointing my belief is we will still see a deal for Brilacidin.
Kevetrin phase 2b studies are on deck for Ovarian cancer.
GLTA Farrell...All IMO